|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 36 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-10 |
4 |
B |
$4.83 |
$85,660 |
I/I |
17,735 |
896,844 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-10 |
4 |
S |
$13.00 |
$5,591 |
I/I |
(430) |
933,109 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-09 |
4 |
S |
$13.00 |
$28,771 |
I/I |
(2,213) |
933,539 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-08 |
4 |
S |
$13.00 |
$793 |
I/I |
(61) |
935,752 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-07 |
4 |
S |
$13.00 |
$793 |
I/I |
(61) |
935,813 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-04 |
4 |
S |
$13.14 |
$141,379 |
I/I |
(10,757) |
935,874 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-03 |
4 |
S |
$13.29 |
$137,270 |
I/I |
(10,327) |
946,631 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-11 |
4 |
B |
$5.28 |
$299,833 |
I/I |
56,822 |
953,666 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-02 |
4 |
S |
$12.94 |
$397,796 |
I/I |
(30,734) |
956,958 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-24 |
4 |
B |
$5.98 |
$70,897 |
I/I |
11,847 |
965,513 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-12 |
4 |
S |
$12.25 |
$747 |
I/I |
(61) |
987,694 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-11 |
4 |
S |
$12.25 |
$33,891 |
I/I |
(2,766) |
987,755 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-10 |
4 |
S |
$12.36 |
$77,523 |
I/I |
(6,270) |
990,521 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-07 |
4 |
S |
$12.25 |
$99,435 |
I/I |
(8,114) |
996,791 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-25 |
4 |
B |
$6.00 |
$212,814 |
I/I |
35,469 |
1,000,982 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-06 |
4 |
S |
$12.35 |
$311,323 |
I/I |
(25,202) |
1,004,905 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-22 |
4 |
B |
$16.67 |
$2,382,705 |
I/I |
142,938 |
1,017,895 |
2.25 |
- |
|
INCY |
Incyte Corp |
10% Owner |
|
2003-09-19 |
4 |
B |
$5.04 |
$2,802,557 |
I/I |
556,350 |
1,020,307 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-05 |
4 |
S |
$12.28 |
$151,769 |
I/I |
(12,355) |
1,030,107 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-04 |
4 |
S |
$12.21 |
$175,555 |
I/I |
(14,383) |
1,042,462 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-23 |
4 |
B |
$16.40 |
$432,557 |
I/I |
26,373 |
1,044,268 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-03 |
4 |
S |
$12.16 |
$299,000 |
I/I |
(24,587) |
1,056,845 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-24 |
4 |
B |
$16.31 |
$402,984 |
I/I |
24,655 |
1,068,923 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
officerTitle |
|
2006-03-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,071,416 |
|
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-12-19 |
4 |
B |
$13.25 |
$3,949,030 |
I/I |
298,040 |
1,078,767 |
1.5 |
- |
|
1397 Records found
|
|
Page 36 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|